Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38358
CAS Number:
175865-59-5
Clorhidrato de valganciclovir
Purity:
≥ 98% (ensayo por titulación)
Synonym(s):
Clorhidrato de monoetilenglicol (L-valina)-2-[(2-amino-1,6-dihidro-6-oxo- 9H- purin-9-il)metoxi]-3-hidroxipropil éster
Documents
$106.96 /250 mg
Tamaño
Request Bulk Quote
Información del producto

Valganciclovir hydrochloride is an antiviral medication primarily used in the treatment and prevention of cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those undergoing organ transplantation or those with HIV/AIDS. This compound is a prodrug of ganciclovir, which means it is converted into its active form in the body, enhancing its efficacy in combating viral replication. Valganciclovir hydrochloride is recognized for its high bioavailability, making it a preferred choice in clinical settings for oral administration.

In addition to its primary use in treating CMV infections, Valganciclovir hydrochloride has shown potential in research settings for its effects on other viral infections and its role in enhancing the immune response. Its unique properties allow for effective dosing regimens, which can lead to improved patient compliance and outcomes. Researchers and healthcare professionals appreciate its versatility and effectiveness, making it a valuable asset in antiviral therapy.

Número CAS
175865-59-5
Fórmula molecular
C14H22N6O5 · HCl
Peso molecular
390.83
Número MDL
MFCD08460118
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
175865-59-5
Fórmula molecular
C14H22N6O5 · HCl
Peso molecular
390.83
Número MDL
MFCD08460118
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Valganciclovir hydrochloride is widely utilized in research focused on:

  • Antiviral Therapy: It is primarily used in the treatment of cytomegalovirus (CMV) infections, especially in immunocompromised patients, such as those undergoing organ transplants. This application is crucial for improving patient outcomes and preventing severe complications.
  • Pharmaceutical Development: Researchers use this compound in the development of new antiviral medications. Its effectiveness against CMV makes it a valuable reference point for creating similar drugs that target viral infections.
  • Clinical Trials: Valganciclovir hydrochloride is often included in clinical trials to assess its efficacy and safety in various populations, providing essential data that can lead to improved treatment protocols.
  • Research on Drug Resistance: It serves as a model compound in studies investigating antiviral drug resistance mechanisms, helping scientists understand how viruses adapt and develop resistance to treatments.
  • Combination Therapy Studies: The compound is frequently tested in combination with other antiviral agents to enhance therapeutic efficacy, offering insights into more effective treatment regimens for viral infections.

Citas